Plasma Aldosterone Is Related to Severity of Obstructive Sleep Apnea in Subjects With Resistant Hypertension
The DOI matches its Crossref record; 38 of the 40 references it cites were found in a registry or an index.
Abstract
Objective Obstructive sleep apnea (OSA) and primary aldosteronism are common in subjects with resistant hypertension; it is unknown, however, if the two disorders are causally related. This study relates plasma aldosterone and renin levels to OSA severity in subjects with resistant hypertension, and in those with equally severe OSA but without resistant hypertension serving as control subjects. Methods Seventy-one consecutive subjects referred to the University of Alabama at Birmingham (UAB) for resistant hypertension (BP uncontrolled on three medications) and 29 control subjects referred to UAB Sleep Disorders Center for suspected OSA were prospectively evaluated by an early morning plasma aldosterone concentration (PAC) and renin level, and by overnight, attended polysomnography. Results OSA (apnea-hypopnea index [AHI] > or = 5/h) was present in 85% of subjects with resistant hypertension. In these subjects, PAC correlated with AHI (rho = 0.44, p = 0.0002) but not renin concentration. Median PAC was significantly lower in control subjects compared to subjects with resistant hypertension (5.5 ng/dL vs 11.0 ng/dL, p Conclusion OSA is extremely common in subjects with resistant hypertension. A significant correlation between PAC and OSA severity is observed in subjects with resistant hypertension but not in control subjects. While cause and effect cannot be inferred, the data suggest that aldosterone excess may contribute to OSA severity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Over 50% of subjects with resistant HTN have underlying OSA.698–700”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [699]
In the citing paper
“OSA is extremely common in patients with RH, with prevalence rates as high as 70% to 90%, and when present, OSA is often severe.272–277”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [277]
In the citing paper
“The high occurrence of OSA in patients with RH has been attributed to increased fluid retention and accompanying upper airway edema, as suggested by studies positively relating the presence and severity of OSA to aldosterone excess and high dietary sodium intake.47,49,277–279”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [277]
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Rechtschaffen, A. (1968) · Medical Entomology and Zoology · Cited by 12,654
Prospective Study of the Association between Sleep-Disordered Breathing and Hypertension
Peppard, P. E., Young, T., Palta, M., & Skatrud, J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005113421901 · Cited by 4,973
Marin, J. M., Carrizo, S. J., Vicente, E., & Agusti, A. G. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71141-7 · Cited by 4,678
Pickering, T. G., Hall, J. E., Appel, L. J., Falkner, B. E., Graves, J., Hill, M. N., Jones, D. W., Kurtz, T., Sheps, S. G., & Roccella, E. J. (2005) · Circulation · doi:10.1161/01.cir.0000154900.76284.f6 · Cited by 3,985
Using the Berlin Questionnaire To Identify Patients at Risk for the Sleep Apnea Syndrome
Netzer, N. C., Stoohs, R. A., Netzer, C. M., Clark, K., & Strohl, K. P. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-7-199910050-00002 · Cited by 2,973
Obstructive Sleep Apnea: Implications for Cardiac and Vascular Disease
Shamsuzzaman, A. S. M., Gersh, B. J., & Somers, V. K. (2003) · JAMA · doi:10.1001/jama.290.14.1906 · Cited by 1,188
High prevalence of unrecognized sleep apnoea in drug-resistant hypertension
Logan, A. G., Perlikowski, S. M., Mente, A., Tisler, A., Tkacova, R., Niroumand, M., Leung, R. S. T., & Bradley, T. D. (2001) · Journal of Hypertension · doi:10.1097/00004872-200112000-00022 · Cited by 960
Becker, H. F., Jerrentrup, A., Ploch, T., Grote, L., Penzel, T., Sullivan, C. E., & Peter, J. H. (2003) · Circulation · doi:10.1161/01.cir.0000042706.47107.7a · Cited by 931
Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension
Calhoun, D. A., Nishizaka, M. K., Zaman, M. A., Thakkar, R. B., & Weissmann, P. (2002) · Hypertension · doi:10.1161/01.hyp.0000040261.30455.b6 · Cited by 763
Self-citation
Cited by
Items 101–200 of 357
Approach to the Patient with Primary Aldosteronism: Utility and Limitations of Adrenal Vein Sampling
Turcu, A. F., & Auchus, R. J. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa952 · Cited by 51
Barceló, A., Piérola, J., Esquinas, C., de la Peña, M., Arqué, M., Alonso‐Fernández, A., Bauçà, J. M., Robles, J., Martín, B. B., & Barbé, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084362 · Cited by 50
“Recent studies have suggested that aldosterone excess may play a role in the relation between hypertension and OSAHS [15],[17],[18].”
BackgroundWolley, M. J., Pimenta, E., Calhoun, D. A., Gordon, R. D., Cowley, D., & Stowasser, M. (2017) · Journal of Human Hypertension · doi:10.1038/jhh.2017.28 · Cited by 50
Self-citationChronic kidney disease in patients with obstructive sleep apnea. A narrative review
Voulgaris, A., Marrone, O., Bonsignore, M. R., & Steiropoulos, P. (2019) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2019.07.001 · Cited by 51
Characterization and treatment of resistant hypertension
Pisoni, R., Ahmed, M. I., & Calhoun, D. A. (2009) · Current Cardiology Reports · doi:10.1007/s11886-009-0059-z · Cited by 49
Self-citationBörgel, J., Springer, S., Ghafoor, J., Arndt, D., Duchna, H.-W., Barthel, A., Werner, S., Van Helden, J., Hanefeld, C., Neubauer, H., et al. (2010) · Clinical Research in Cardiology · doi:10.1007/s00392-010-0148-4 · Cited by 47
“It was previously hypothesized that SA could induce hyperaldosteronism [ 9 , 10].”
BackgroundNew frontiers in pharmacologic obstructive sleep apnea treatment: A narrative review
Schütz, S. G., Dunn, A., Braley, T. J., Pitt, B., & Shelgikar, A. V. (2021) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2021.101473 · Cited by 47
Bosanquet, J. P., Bade, B. C., Zia, M., Karo, A., Hassan, O., Hess, B. T., & Dabbagh, O. C. (2010) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029610389023 · Cited by 47
Primary Aldosteronism and Obstructive Sleep Apnea: Is This A Bidirectional Relationship?
Prejbisz, A., Kołodziejczyk‐Kruk, S., Lenders, J. W. M., & Januszewicz, A. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-122887 · Cited by 45
Cerebro-Cardiovascular Risk, Target Organ Damage, and Treatment Outcomes in Primary Aldosteronism
Lin, X., Ullah, M. H. E., Xiong, W., Xu, F., Shan, S., Lei, L.-M., Yuan, L., & Liu, J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.798364 · Cited by 45
Loh, H. H., Lim, Q. H., Chai, C.-S., Goh, S. L., Lim, L., Yee, A. H. A., & Sukor, N. (2022) · Journal of Sleep Research · doi:10.1111/jsr.13726 · Cited by 45
Obesity, sleep apnea, aldosterone, and hypertension
Goodfriend, T. L. (2008) · Current Hypertension Reports · doi:10.1007/s11906-008-0042-x · Cited by 44
Sleep-Disordered Breathing and Cardiac Arrhythmias
Bitter, T., Fox, H., Gaddam, S., Horstkotte, D., & Oldenburg, O. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.04.022 · Cited by 44
Aldosteronism and Resistant Hypertension
Acelajado, M. C., & Calhoun, D. A. (2011) · International Journal of Hypertension · doi:10.4061/2011/837817 · Cited by 44
Self-citationManagement of patients with resistant hypertension: current treatment options
Dudenbostel, T., Kumar, N., & Calhoun (2013) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s33984 · Cited by 36
“Recent studies indicate that obstructive sleep apnea is significantly associated with increased aldosterone excretion(12) and there seems to be a significant correlation between aldosterone levels and the severity of obstructive sleep apnea.(15) It is hypothesized that chronic parapharyngeal fluid retention, mediated…”
Aldosterone excess and resistance to 24-h blood pressure control
Pimenta, E., Gaddam, K. K., Pratt-Ubunama, M. N., Nishizaka, M. K., Cofield, S. S., Oparil, S., & Calhoun, D. A. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282a9be30 · Cited by 43
Self-citationResistant Hypertension and Obstructive Sleep Apnea
Khan, A., Patel, N. K., O’Hearn, D. J., & Khan, S. (2013) · International Journal of Hypertension · doi:10.1155/2013/193010 · Cited by 42
Tsioufis, C. P., Kasiakogias, A., Thomopoulos, C., Manolis, A. J., & Stefanadis, C. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e328336ed85 · Cited by 43
Secondary Causes of Hypertension
Taler, S. J. (2008) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2008.06.001 · Cited by 42
Oxygen desaturation during sleep in hepatopulmonary syndrome†
Palma, D. T., Philips, G., Arguedas, M. R., Harding, S. M., & Fallon, M. B. (2008) · Hepatology · doi:10.1002/hep.22143 · Cited by 41
Self-citationSympathetic neural mechanisms in human hypertension
Victor, R. G., & Shafiq, M. M. (2008) · Current Hypertension Reports · doi:10.1007/s11906-008-0045-7 · Cited by 41
Obstructive Sleep Apnea, Hypercoagulability, and the Blood–Brain Barrier
Zolotoff, C., Bertoletti, L., Gozal, D., Mismetti, V., Flandrin‐Gresta, P., Roche, F., & Perek, N. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10143099 · Cited by 39
Aldosterone Inhibition and Cardiovascular Protection: More Important Than it Once Appeared
Martínez, F. A. (2010) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-010-6256-6 · Cited by 39
“More recently, some provocative and consistent publications are suggesting the benefit of aldosterone antagonism in patients with sleep apnea, as part of their resistant hypertension or heart failure syndromes [35, 36].”
BackgroundVascular changes, Cardiovascular Disease and Obstructive Sleep Apnea
Ramar, K., & Caples, S. M. (2011) · Future Cardiology · doi:10.2217/fca.10.123 · Cited by 38
Resistant/Refractory Hypertension and Sleep Apnoea: Current Knowledge and Future Challenges
Oscullo, G., Torres, G., Campos‐Rodríguez, F., Posadas, T., Reina-González, Á., Sapiña-Beltrán, E., Barbé, F., & Martínez‐García, M. Á. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111872 · Cited by 40
AlMarabeh, S., Abdulla, M. H., & O’Halloran, K. D. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00465 · Cited by 37
Sleep apnea syndrome in endocrine clinics
Ceccato, F., Bernkopf, E., & Scaroni, C. M. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0338-z · Cited by 37
“Aldosterone excess may play a pathophysiological part in the relationship between hypertension and OSAS, since higher plasma aldosterone concentrations and OSAS were seen in patients with refractory hypertension [63], and the prevalence of OSAS was higher in subjects with primary hyperaldosteronism than in patients wi…”
BackgroundObstructive Sleep Apnea Syndrome (OSAS) and Cardiovascular System
Lombardi, C., Tobaldini, E., Montano, N., Losurdo, A., & Parati, G. (2017) · La Medicina del Lavoro · doi:10.23749/mdl.v108i4.6427 · Cited by 36
Obstructive sleep apnea, hypertension, resistant hypertension and cardiovascular disease.
Jehan, S., Zizi, F., Pandi-Perumal, S. R., McFarlane, S. I., Jean‐Louis, G., & Myers, A. K. (2020) · PubMed · Cited by 36
Obstructive sleep apnea syndrome and chronic kidney disease: a new cardiorenal risk factor
Özkök, A., Kanbay, A., Odabaş, A. R., Covic, A. C., & Kanbay, M. (2014) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2013.804546 · Cited by 37
Morbidité cardiovasculaire associée au syndrome d’apnée obstructive du sommeil
Destors, M., Tamisier, R., Baguet, J. P., Levy, P. A., & Pépin, J. (2014) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2013.12.003 · Cited by 37
de Souza, F., Muxfeldt, E. S., Margallo, V. S., Cortez, A. F., Cavalcanti, A. H., & Salles, G. F. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001254 · Cited by 35
Association of aldosterone excess and apnea-hypopnea index in patients with resistant hypertension
Xiao, K., Guo, W., Hu, P., Hu, C., Zhang, H., Peng, C., & Wang, X. (2017) · Scientific Reports · doi:10.1038/srep45241 · Cited by 34
Mecanismos e tratamento da hipertensão arterial refratária
Pimenta, E., Calhoun, D. A., & Oparil, S. (2007) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2007000600009 · Cited by 37
Self-citationWang, L., Li, N., Yao, X., Chang, G., Zhang, D., Heizhati, M., Wang, M., Luo, Q., & Kong, J. (2017) · BioMed Research International · doi:10.1155/2017/8295010 · Cited by 33
Resistant Hypertension Workup and Approach to Treatment
Makris, A. P., Seferou, M., & Papadopoulos, D. P. (2010) · International Journal of Hypertension · doi:10.4061/2011/598694 · Cited by 32
Obstructive Sleep Apnea and the Risk of Atopic Dermatitis: A Population-Based Case Control Study
Tien, K., Chou, C., Lee, S.-Y., Yeh, N.-C., Yang, C.-Y., Yen, F.-C., Wang, J., & Weng, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089656 · Cited by 32
Urbanik, D., Martynowicz, H., Mazur, G. J., Poręba, R., & Gać, P. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030836 · Cited by 32
Epstein, M., & Duprez, D. A. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.01.039 · Cited by 31
Siddiqui, M., Bhatt, H., Judd, E. K., Oparil, S., & Calhoun, D. A. (2020) · American Journal of Hypertension · doi:10.1093/ajh/hpaa042 · Cited by 30
Self-citationImpact of Body Composition on Sleep and Its Relationship with Sleep Disorders: Current Insights
Kawasaki, Y., Kitamura, E., & Kasai, T. (2023) · Nature and Science of Sleep · doi:10.2147/nss.s340946 · Cited by 30
Resistant Hypertension and Obstructive Sleep Apnea: The Sparring Partners
Thomopoulos, C., Michalopoulou, H., Kasiakogias, A., Kefala, A., & Makris, T. K. (2011) · International Journal of Hypertension · doi:10.4061/2011/947246 · Cited by 30
“However, no correlation was noted between OSA and aldosterone levels in subjects without resistant hypertension with equally severe OSA [30].”
BackgroundCardiorespiratory interaction with continuous positive airway pressure
Pengo, M. F., Bonafini, S., Fava, C., & Steier, J. S. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.01.39 · Cited by 30
Primary Aldosteronism and Obstructive Sleep Apnea: Casual Association or Pathophysiological Link?
Pecori, A., Buffolo, F., Pieroni, J., Forestiero, V., Sconfienza, E., Veglio, F., Mulatero, P., & Monticone, S. (2020) · Hormone and Metabolic Research · doi:10.1055/a-1133-7255 · Cited by 30
Kasai, T., Kohno, T., Shimizu, W., Ando, S., Joho, S., Osada, N., Kato, M., Kario, K., Shiina, K., Tamura, A., et al. (2024) · Circulation Journal · doi:10.1253/circj.cj-23-0489 · Cited by 28
Obstructive sleep apnea and the metabolic syndrome
Lam, J., & Ip, M. (2009) · Expert Review of Respiratory Medicine · doi:10.1586/ers.09.10 · Cited by 27
Walia, H. K., Griffith, S. D., Foldvary‐Schaefer, N., Thomas, G., Bravo, E. L., Moul, D. E., & Mehra, R. (2015) · CHEST Journal · doi:10.1378/chest.15-0697 · Cited by 27
Sato, A. (2015) · Hypertension Research · doi:10.1038/hr.2015.19 · Cited by 26
Hypertension in diverse populations: a New York State Medicaid clinical guidance document
Wrobel, M. J., Figge, J. J., & Izzo, J. L. (2011) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2011.05.003 · Cited by 26
The Demystification of Secondary Hypertension: Diagnostic Strategies and Treatment Algorithms
Hirsch, J. S., & Hong, S. (2019) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-019-0790-8 · Cited by 26
Treatment of hypertension in patients with diabetes—an update
Bakris, G. L., & Sowers, J. R. (2009) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2009.01.001 · Cited by 26
Castro, M. A., Ruiz-Sánchez, J. G., Ramírez, P. A. P., Rojas‐Marcos, P. M., Aguilera-Saborido, A., Cerezo, J. F. G., Lazareno, N. L., Quesada, M. E. T., Ramos, J. G., Oriola, J., et al. (2024) · Endocrine · doi:10.1007/s12020-024-03751-1 · Cited by 25
“…atrial fi brillation) [24, 55, 56], HT [57, 58], insulin resistance [59], albuminuria [58] and other complex mechanisms related to metabolic diseases [60] such as obstructive sleep apnea [61 – 63], obesity [64 – 66], diabetes mellitus [8, 67 – 69] and alterations of calcium metabolism [70].”
Resistant Hypertension and Chronic Kidney Disease: a Dangerous Liaison
Wolley, M. J., & Stowasser, M. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0641-x · Cited by 25
Grassi, G. M., Calhoun, D. A., Mancia, G., & Carey, R. M. (2019) · Current Hypertension Reports · doi:10.1007/s11906-019-0974-3 · Cited by 25
Self-citationRecent advances in understanding and managing resistant/refractory hypertension
Doumas, M. N., Imprialos, K. P., Kallistratos, M. S., & Manolis, A. J. (2020) · F1000Research · doi:10.12688/f1000research.21669.1 · Cited by 25
Resistant Hypertension: Where are We Now and Where Do We Go from Here?
Pathan, M. K., & Cohen, D. L. (2020) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s223334 · Cited by 24
Bambhroliya, Z., Sandrugu, J., Lowe, M., Okunlola, O. I., Raza, S., Osasan, S. A., Sethia, S., Batool, T., & Hamid, P. (2022) · PubMed Central · doi:10.7759/cureus.26325 · Cited by 24
Conséquences rénales de l’obésité
Laville, M. (2011) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2010.11.007 · Cited by 24
Primary aldosteronism and obstructive sleep apnea: What do we know thus far?
Loh, H. H., & Sukor, N. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.976979 · Cited by 24
Sleep-Disordered Breathing and Resistant Hypertension
Wang, A. Y.-M. (2014) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2014.08.006 · Cited by 23
Role of Mineralocorticoid Receptors in Obstructive Sleep Apnea and Metabolic Syndrome
Valaiyapathi, B., & Calhoun, D. A. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0819-5 · Cited by 23
Self-citationObstructive sleep apnea syndrome, continuous positive airway pressure and treatment of hypertension
Floras, J. S. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.06.024 · Cited by 23
“hypertension, but not in normotensive or controlled hypertensive subjects, consistent with a pathogenic role for volume excess in many of the former cohort (50).”
Resistant Hypertension and Sleep Apnea: Pathophysiologic Insights and Strategic Management
Williams, S. K., Ravenell, J. E., Jean‐Louis, G., Zizi, F., Underberg, J. A., McFarlane, S. I., & Ogedegbe, G. G. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0161-z · Cited by 22
Loh, H. H., & Sukor, N. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-019-0294-8 · Cited by 21
Effects of heart failure and its pharmacological management on sleep
Jiménez, J. A., Greenberg, B., & Mills, P. J. (2011) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2011.02.006 · Cited by 21
“Effects of Aldosterone Antagonists on Sleep—Data suggests that aldosterone excess may contribute to OSA severity [20].”
BackgroundHypertension: Issues in control and resistance
Wofford, M. R., & Minor, D. S. (2009) · Current Hypertension Reports · doi:10.1007/s11906-009-0055-0 · Cited by 21
Sleep-Disordered Breathing and Arrhythmia in Heart Failure Patients
Fox, H., Bitter, T., Horstkotte, D., & Oldenburg, O. (2017) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2017.01.003 · Cited by 20
“SDB with increased levels of angiotensin II and aldosterone in humans.(43,44) SDB with intermittent hypoxemia during repetitive airflow cessations also can lead to endothelial dysfunction.”
BackgroundWijkman, M. O., Malachias, M. V. B., Claggett, B. L., Cheng, S. C., Matsushita, K., Shah, A. M., Jhund, P. S., Coresh, J., Solomon, S. D., & Vardeny, O. (2021) · Journal of Clinical Hypertension · doi:10.1111/jch.14269 · Cited by 20
Townsend, R. R., & Epstein, M. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07316 · Cited by 19
Badran, M., Bender, S. B., & Gozal, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032245 · Cited by 19
Prospective Screening for Primary Aldosteronism in Patients With Suspected Obstructive Sleep Apnea
Chee, M. R., Hoo, J., Libianto, R., Gwini, S. M., Hamilton, G. S., Narayan, O. P., Young, M. J., Fuller, P. J., & Yang, J. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.16902 · Cited by 18
Who should be screened for primary aldosteronism? A comprehensive review of current evidence
Huang, W., Lin, Y., Wu, V., Chen, C., Siddique, S., Chia, Y. C., Tay, J. C., Guruprasad, S., Cheng, H., & Kario, K. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14558 · Cited by 18
Treating resistant hypertension: role of renal denervation
Mahfoud, F., Urban, D., Ewen, S., Ukena, C., Linz, D., & Böhm, M. (2013) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s33958 · Cited by 18
“Obstructive sleep apnea (OSA) syndrome has been observed in more than two-thirds of patients with resistant hypertension, while only 38% of patients with controlled hypertension have been found to meet the criteria of this syndrome.(21,22) Chronic kidney disease is not only a consequence of resistant hypertension but…”
Use of continuous positive airway pressure for sleep apnea in the treatment of hypertension
Denker, M. G., & Cohen, D. L. (2014) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000047 · Cited by 18
“However, among hypertensive patients who subsequently undergo polysomnography testing as part of a study protocol, many have evidence of OSA that was previously undiagnosed [1,15,16].”
BackgroundThunström, E. Ö., Manhem, K., Yucel‐Lindberg, T., Rosengren, A., Lindberg, C., & Peker, Y. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201602-126oc · Cited by 18
The role of mineralocorticoid receptor antagonists (MRAs) in very old patients with heart failure
Pitt, B. (2011) · Heart Failure Reviews · doi:10.1007/s10741-011-9286-7 · Cited by 18
“Aldosterone levels are increased in patients with sleep apnea and correlate with the number of apneic episodes [22].”
BackgroundSleep Disturbances and Resistant Hypertension: Association or Causality?
Pereira, D. C. G., Pedrosa, R. P., Lorenzi‐Filho, G., & Drager, L. F. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0459-3 · Cited by 18
The effect of treatment for sleep apnoea on determinants of blood pressure control
Casitas, R., Martínez-Cerón, E., Galera, R., Cubillos-Zapata, C., González-Villalba, M. J., Fernández-Navarro, I., Sánchez, B., García-Sánchez, A., Zamarrón, E., & García-Río, F. (2017) · European Respiratory Journal · doi:10.1183/13993003.01261-2017 · Cited by 17
Bhandari, S. K., Shi, J. M., Molnar, M. Z., Rasgon, S. A., Derose, S. F., Kovesdy, C. P., Calhoun, D. A., Kalantar‐Zadeh, K., Jacobsen, S. J., & Sim, J. J. (2016) · Respirology · doi:10.1111/resp.12840 · Cited by 17
Self-citationPathophysiology, Diagnosis, and Treatment of Mineralocorticoid Disorders
Magill, S. B. (2014) · Comprehensive physiology · doi:10.1002/cphy.c130042 · Cited by 17
Hyperaldosteronism: Screening and Diagnostic Tests
Sabbadin, C., & Fallo, F. (2016) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-016-0136-5 · Cited by 18
“Another interesting association has been described between hyperaldosteronism and severity of obstructive sleep apnea (OSA) in patients with resistant hypertension [17].”
BackgroundTreatment of hypertension in patients with diabetes—an update
Bakris, G. L., Sowers, J. R., Glies, T. D., Black, H. R., Izzo, J. L., Materson, B. J., Oparil, S., & Weber, M. A. (2010) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2010.03.005 · Cited by 17
Difficult-to-Treat or Resistant Hypertension: Etiology, Pathophysiology, and Innovative Therapies
Papademetriou, V., Tsioufis, C. P., Gradman, A. H., & Punzi, H. A. (2011) · International Journal of Hypertension · doi:10.4061/2011/438198 · Cited by 16
Epidemiologie und Ätiologie der therapieresistenten Hypertonie
Schirpenbach, C., & Reincke, M. (2008) · Der Internist · doi:10.1007/s00108-008-2194-9 · Cited by 17
Yoshida, Y., & Shibata, H. (2024) · Hypertension Research · doi:10.1038/s41440-024-01970-7 · Cited by 15
“It has been reported that PA patients had a high rate of OSAS complications [23] and that PAC correlated with OSAS severity [24].”
Sleep disordered breathing in cardiac surgery patients: The NU-SLEEP trial
Sezai, A., Akahoshi, T., Osaka, S., Yaoita, H., Arimoto, M., Hata, H., Tanaka, M., Sekino, H., & Akashiba, T. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.11.069 · Cited by 15
Screening for Primary Aldosteronism is Underutilized in Patients with Obstructive Sleep Apnea
Conroy, P. C., Hernandez, S., Graves, C. E., Menut, K. C., Pearlstein, S., Liu, C., Shen, W. T., Gosnell, J. E., Sosa, J. A., Roman, S. A., et al. (2021) · The American Journal of Medicine · doi:10.1016/j.amjmed.2021.07.041 · Cited by 15
Wang, Q., Zeng, H., Dai, J., Zhang, M., & Shen, P. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1497703 · Cited by 15
Mirrakhimov, A. E. (2012) · Sleep And Breathing · doi:10.1007/s11325-012-0755-6 · Cited by 14
Treatment of Primary Aldosteronism Reduces the Probability of Obstructive Sleep Apnea
Wang, E. Y., Chomsky‐Higgins, K. H., Chen, Y., Nwaogu, I. Y., Seib, C. D., Shen, W. T., Duh, Q., & Suh, I. (2018) · Journal of Surgical Research · doi:10.1016/j.jss.2018.10.040 · Cited by 13
The risk of obstructive sleep apnea among patients with type 2 diabetes mellitus
Umoh, V., Akpan, E., Ekrikpo, U. E., Idung, A. U., & Ekpe, E. E. (2020) · Nigerian Medical Journal · doi:10.4103/nmj.nmj_129_19 · Cited by 13
Born-Frontsberg, E., & Quinkler, M. O. (2008) · Der Internist · doi:10.1007/s00108-008-2195-8 · Cited by 14
Sympathetic hyperactivity in patients with hypertension: pathogenesis and treatment. Part I
Safaryan, A. S., & Sargsyan, V. D. (2020) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2020-2693 · Cited by 12
The Association of Sleep Disordered Breathing with Heart Failure and Other Cardiovascular Conditions
Stopford, E., Ravi, K., & Nayar, V. (2013) · Cardiology Research and Practice · doi:10.1155/2013/356280 · Cited by 12
Sleep quality in patients with primary aldosteronism
German Conn’s Registry, Hanusch, F. M., Fischer, E., Lang, K., Diederich, S., Endres, S., Allolio, B., Beuschlein, F., Reincke, M., & Quinkler, M. O. (2014) · HORMONES · doi:10.1007/bf03401320 · Cited by 12
Ruiz-Sánchez, J. G., Sánchez, Á. F., Cárdenas‐Salas, J., Fernández-Cagigao, Y., Bellassai, E. R. A., Rossello, G., Fernández‐Fernández, B., Moreno, B. J., Paniagua, A., Vázquez, C., et al. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003822 · Cited by 11
Blood pressure profile and nocturnal oxygen desaturation
Lattanzi, S., Brigo, F., & Silvestrini, M. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13259 · Cited by 11
Primary Hyperaldosteronism: When to Suspect It and How to Confirm Its Diagnosis
Ruiz-Sánchez, J. G., Pazos, M., Meneses, D., & Rünkle, I. (2022) · Endocrines · doi:10.3390/endocrines3010003 · Cited by 11
Wang, H., Heizhati, M., Li, N., Gan, L., Lin, M., Yang, W., Li, M., Yao, L., Liu, M., Maitituersun, A., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1016804 · Cited by 11
Tani, S., Takahashi, A., Nagao, K., & Hirayama, A. (2014) · International Heart Journal · doi:10.1536/ihj.14-034 · Cited by 11
Metadata
- Authors
- Pratt-Ubunama, M. N., Nishizaka, M. K., Boedefeld, R. L., Cofield, S. S., Harding, S. M., & Calhoun, D. A.
- Affiliations
- University of Alabama at Birmingham (US)
- Corresponding author
- Calhoun, David A.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2007-02
- Volume
- 131
- Issue
- 2
- Pages
- 453-459
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2119080429
- Semantic Scholar
- ce0dd68286168a857920d1b2f90f2b9a608a19c0
- Cited by
- 331
- References
- 40
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 12 · 2023: 9 · 2022: 14 · 2021: 8 · 2020: 16 · 2019: 22 · 2018: 18 · 2017: 18 · 2016: 21 · 2015: 20 · 2014: 35 · 2013: 20 · 2012: 28
- FWCI
- 13.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- CHEST Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Pharmacology (medical) › Apelin-related biomedical research
- Keywords
- obstructive sleep apnea, resistant hypertension, plasma aldosterone, renin, apnea-hypopnea index, OSA severity, primary aldosteronism, sex differences, aldosterone excess
- MeSH terms
- Adult, Aged, Aldosterone, Female, Humans, Hypertension, Male, Middle Aged, Prospective Studies, Respiratory Function Tests, Severity of Illness Index, Case-Control Studies, Polysomnography, Sleep Apnea, Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.